MilliporeSigma, a life science and high technology company, has opened its M Lab Collaboration Center in Shanghai, it was reported on Friday.
The facility includes an integrated lab with customisable solutions, validation services, training and hands-on applications to help advance drug development.
The M Lab Collaboration Center covers around a 10,000 square metre area and is situated at Pudong, at the heart of the biomedical sciences and research community in Shanghai.
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Scancell initiates SCOPE trial's iSCIB1+ cohort
Valneva launches Phase 1 trial for next-generation Zika vaccine
argenx obtains VYVGART approval for primary immune thrombocytopenia in Japan
Bio-Thera Solutions' BAT8006 phase II Study receives US FDA IND approval
Biocytogen and ABL Bio collaborate on development of new bispecific antibody-drug conjugates
BenevolentAI reports positive Phase Ia safety and pharmacokinetic data for BEN-8744
AstraZeneca announces US approval for Ultomiris for NMOSD treatment